Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Feb 12;17(3):371-373.
doi: 10.1016/j.jcin.2023.12.032.

P2Y12 Inhibitors in Chronic Coronary Syndromes Undergoing Elective PCI: Any Niche for Potent Agents?

José Luis Ferreiro  1
Affiliations
Free article
Editorial

P2Y12 Inhibitors in Chronic Coronary Syndromes Undergoing Elective PCI: Any Niche for Potent Agents?

José Luis Ferreiro. JACC Cardiovasc Interv. .
Free article
No abstract available

Keywords: P2Y(12) inhibitors; antiplatelet therapy; chronic coronary syndrome; elective percutaneous coronary intervention.

PubMed Disclaimer

Conflict of interest statement

Funding Support and Author Disclosures Dr Ferreiro has received honoraria for lectures from Eli Lilly, Daiichi Sankyo, AstraZeneca, Pfizer, Abbott, Boehringer Ingelheim, Bristol Myers Squibb, Rovi, Terumo, and Ferrer; has received consulting fees from AstraZeneca, Eli Lilly, Ferrer, Boston Scientific, Pfizer, Boehringer Ingelheim, Daiichi Sankyo, Bristol Myers Squibb, and Biotronik; and has received research grants from AstraZeneca.

Comment on

  • Ticagrelor vs Clopidogrel for Complex Percutaneous Coronary Intervention in Chronic Coronary Syndrome.
    Lattuca B, Mazeau C, Cayla G, Ducrocq G, Guedeney P, Laredo M, Dumaine R, El Kasty M, Kala P, Nejjari M, Hlinomaz O, Morel O, Varenne O, Leclercq F, Payot L, Spaulding C, Beygui F, Rangé G, Motovska Z, Portal JJ, Vicaut E, Collet JP, Montalescot G, Silvain J; ALPHEUS Investigators. Lattuca B, et al. JACC Cardiovasc Interv. 2024 Feb 12;17(3):359-370. doi: 10.1016/j.jcin.2023.12.011. JACC Cardiovasc Interv. 2024. PMID: 38355265 Clinical Trial.

References

MeSH terms

Substances

LinkOut - more resources